ValidationHealthcare

Comprehensive analysis of FDA audit trail compliance

Recent FDA observations keep finding the same audit trail failures. This analysis covers what inspectors expect, where companies fall short, and how we built a global Part 11 program that closed the gaps.

Client: Global healthcare corporation

The challenge

21 CFR Part 11 sets the FDA's rules for electronic records and electronic signatures. It applies to drug, device, biotech and biologics makers, CROs and other FDA-regulated companies, and requires controls such as system validation, audit trails, electronic signatures and documentation for systems that process records required by predicate rules.

FDA warning letters keep citing the same audit trail problems: critical user actions not recorded, logs that are incomplete or overwritten, no reviewer accountability, and reliance on visual checks instead of system data. Shared logins are a common root cause, because they make it impossible to attribute an action to a person.

Our client, a global healthcare corporation, faced these gaps across divisions. It needed one global interpretation of Part 11, executive support to drive it, and a way to add new controls without disrupting operations.

Our approach

  • Secured top-level executive sponsorship, framing compliance as a business-continuity issue.
  • Built a targeted plan for each Part 11 subsection with high noncompliance, starting with audit trails and electronic signatures.
  • Wrote global corporate policies so every division interpreted and applied the regulation the same way.
  • Ran training and awareness programs for employees at every level.
  • Implemented software tools for operational checks, authority checks and document control.
  • Managed rollout across departments and locations with a structured project plan.
  • Set up regular audits and continuous monitoring to keep the controls working.

Results

  • Improved compliance in the Part 11 areas previously flagged, reducing regulatory risk.
  • Stronger data integrity and security through tighter controls and regular audits.
  • Leaner, less error-prone compliance processes.

What FDA reviewers expect from an audit trail

Time stampingUser actions and system events recorded with date and time from a reliable, synchronized clock (typically central server time).
User identificationEvery action linked to a unique user ID, so it can be attributed to one person. No shared logins.
Action detailThe type of action, the data element affected, and the previous and new values for any change.
Immutability and securityAudit trail data can't be altered or deleted, and is protected from unauthorized access, with regular backups.
Review and archivingAudit trails are reviewed, archived for the required retention period, and readily available during an inspection.

Facing a similar challenge?

Tell us about your project and we will share how we would approach it.

What happens next

  1. Tell us what you need: a role, a project, or both.
  2. A specialist in that area gets back to you within one business day.
  3. You get a screened shortlist of candidates, or a scoped plan for the project.

(415) 251-6201 · info@sqasolution.com

Thank you. We received your message.

Someone from our team will get back to you within one business day.